Presurgical Planning With Functional MRI (fMRI) Mapping of Motor Cortex in Patients With Cerebral Tumors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00724737|
Recruitment Status : Completed
First Posted : July 29, 2008
Last Update Posted : May 18, 2017
|Condition or disease||Intervention/treatment||Phase|
|Brain Tumors||Procedure: Presurgical MRI Procedure: functional MRI (fMRI) of the brain||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||23 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Presurgical Planning With Motion Corrected fMRI Mapping of Motor Cortex in Patients With Cerebral Tumors|
|Actual Study Start Date :||July 2006|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||December 2013|
Active Comparator: fMRI of the brain, no surgery
Healthy volunteers will undergo an fMRI (functional MRI of the brain).
Procedure: functional MRI (fMRI) of the brain
Healthy subjects will be undergo a brain fMRI of the brain. fMRI is a "functional" scan, meaning that subjects will be asked to perform tasks (such as finger tapping or picture identification) during the MRI scan.
Experimental: fMRI of the brain, presurgical
Patients scheduled to have brain surgery will undergo an fMRI (functional MRI of the brain).
Procedure: Presurgical MRI
People who are scheduled to have brain surgery with undergo a fMRI of the brain before surgery. This is a "functional" scan, meaning that subjects will be asked to perform tasks (such as finger tapping or picture identification) during the MRI scan.
- Determining whether fMRI mapping is as effective as invasive presurgical mapping. [ Time Frame: 2 weeks ]Subjects will be followed for the duration of their hospital stay with an expected average of 2 weeks.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00724737
|United States, Michigan|
|University of Michigan Health System|
|Ann Arbor, Michigan, United States, 48109|
|Principal Investigator:||Boklye Kim, M.D.||University of Michigan|